Matrix metalloproteinase-9 activity in the plasma of patients after surgical resection of endometriomas

Fertility and Sterility

Volumn 85, Issue 6, 2006, Pages 1847-1848

  Abdallah, Maher Ali ^a   Kang, Steveq ^a   Nakajima, Steven T ^a   Gercel Taylor, Cicek ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; ORAL CONTRACEPTIVE AGENT;

ARTICLE; CANCER SURGERY; CARCINOGENESIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRIUM TUMOR; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MENSTRUAL CYCLE; ORAL CONTRACEPTION; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION;

ENDOMETRIOSIS; ENZYME ACTIVATION; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 9; PILOT PROJECTS; POSTOPERATIVE PERIOD;

EID: 33744510278     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2005.11.043     Document Type: Article

References (3)

1. Salamonsen L.A., and Woolej D.E. Matrix metalloproteinases and their tissue inhibitors in endometrial remodeling and menstruation. Reprod Med Rev 5 (1996) 185-203
2. Bruner K.L., Matrisran L.M., Rudgers W.H., Gersteon F., and Osteen K.G. Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. J Clin Invest 99 (1997) 2851-2857
3. Koks C.A.M., Groothuis P.G., Slaats P., Dunselman G.A.J., de Goeij A.F.P.M., and Evers J.L.H. MMP and their tissue inhibitors in antegradely shed menstruum and peritoneal fluid. Fertil Steril 73 (2000) 604-612